Arkolith/Insider Trading/RGRX/Form 4

Finkelstein J J

President and CEO, DirectorREGENERX BIOPHARMACEUTICALS INC (RGRX) · full profile →Form 4 · filed Jul 6, 2021
Net Buying
Open-Market Buys
$15K
Open-Market Sells
$0
Net Open-Market Flow
$15K
Transactions
3
1 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)75K$0.20$15K1.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 30, 2021Buy(P)56K—$056K
Jun 30, 2021Buy(P)56K—$056K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000914190-21-000193) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML